Corvus Pharmaceuticals, Inc. — Director's Dealing 2016

Dec 8, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Corvus Pharmaceuticals, Inc. (CRVS)
CIK: 0001626971
Period of Report: 2016-12-07

Reporting Person: MILLER RICHARD A MD (Director, President and CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-12-07	Stock Option (Right to Buy)	$16.37	A	160000	Acquired	2026-12-07	Common Stock (160000)	Direct

Footnotes

F1: The underlying shares subject to the option vest and become exercisable as to one-forty-eighth (1/48th) of the shares subject to the option in successive, equal monthly installments measured from December 7, 2016, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.